AMBER CARRIVEAU: Open Payments
NPI 1851522502 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 27 payments from 16 companies in 2025. Trend: 2023 $1,274 · 2024 $2,560 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $240 |
| Novo Nordisk Inc | 5 | $172 |
| Astellas Pharma US Inc | 2 | $43 |
| Edwards Lifesciences Corporation | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Boston Scientific Corporation | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| IBSA Pharma Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: AIRSUPRA, Wegovy, Veozah, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, WaveWriter Alpha Prime 16, SHINGRIX, GVOKE HYPOPEN, Tirosint.
Industry payments across CO — which companies pay providers there.
